ARCHIVES

NCI advisors approve recompetition of $62 million phase II contracts program.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

Concept Approval: NCI To Solicit “White Papers” For Technology Development Ideas

July 3, 1998

NIH Breaks Ground For Clinical Center

November 14, 1997

ORI Misconduct Findings Announced In Two Cases

July 12, 1996

‘Be Careful We’re Not Fighting Old Battles’ On Study Section Issue

September 20, 1991

Centers: Bookman Leaves Fox Chase for Arizona

September 11, 2009